Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
47 Ventures
New YorkPre-Seed–Growth$150K – $2M
2 people
Arkitekt Ventures
New YorkSeed–Series A$100K – $10M
2 people
Ataraxia VC
San FranciscoSeed–Series A$50K – $1M
2 people
Extens
ParisSeries A–Series B$3.2M – $16.2M
2 people
Health Technology Holding (HTH)
Pre-Seed–Series B$500K – $1M
2 people
Highbury Holdings
SeattleSeed–Series B$100K – $10M
2 people
Horizon Technology Finance
FarmingtonGrowth–Late Stage$3M – $50M
2 people
Infinity Group
Tel AvivGrowth$1M – $10M
2 people
KittyHawk Ventures
Silicon ValleySeed–Late Stage$250K – $15M
2 people
Klein & Partners AG
ZugGrowth–Late Stage$550K – $5.5M
2 people
Lewis & Clark AgriFood
St. LouisSeries A–Late Stage$2M – $10M
2 people
London & Scottish Investment Partners
EdinburghSeed–Growth$130K – $320K
2 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
2 people
New Business Venture Fund
ReykjavíkSeed–Series B$216K – $4.3M
2 people
Savant Venture Fund
Cape TownPre-Seed–Series A
2 people
ScienceVest
New YorkPre-Seed–Seed$125K
2 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
2 people
VTC Ventures
RoanokePre-Seed–Series B$100K – $5M
6 people
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
ACORN BIOVENTURES
New YorkSeed–Late Stage
4 people
Cobro Ventures
McleanSeed–Series A
4 people
Asbis
Limassol
Cape Fear BioCapital
DurhamPre-Seed–Series B
3 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.











